S-1 treatment for chemorefractory thymic carcinoma

Journal of Thoracic Oncology

Volumn 3, Issue 9, 2008, Pages 1076-

  Ono, Akira ^a   Naito, Tateaki ^a   Yamamoto, Nobuyuki ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; AMRUBICIN; CARBOPLATIN; CD5 ANTIGEN; GEMCITABINE; PACLITAXEL; TS 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIMETABOLITE; OXONIC ACID; S 1 (COMBINATION); TEGAFUR;

AGED; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INOPERABLE CANCER; LETTER; LUNG METASTASIS; LUNG NODULE; MALE; NAUSEA; PRIORITY JOURNAL; THORAX PAIN; THROMBOCYTOPENIA; THYMIC SQUAMOUS CELL CARCINOMA; THYMUS CANCER; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR VOLUME; DRUG COMBINATION; DRUG RESISTANCE; ENZYME IMMUNOASSAY; PATHOLOGY; RADIOGRAPHY; SALVAGE THERAPY; THORAX RADIOGRAPHY; THYMOMA; TREATMENT OUTCOME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; OXONIC ACID; RADIOGRAPHY, THORACIC; SALVAGE THERAPY; TEGAFUR; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 58149130163     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318183af9c     Document Type: Letter

References (5)

1. Yano M, Sasaki H, Yokoyama T, et al. Thy-mic carcinoma: 30 cases at a single institution. J Thorac Oncol 2008;3:265-269.
2. Kurup A, Burns M, Dropcho S, et al. Phase II study of Gefitinib treatment in advanced thymic malignancies. Am Soc Clin Oncol 2005; 23:7068 (abstract).
3. Loehrer PJ, Yiannoutsos CT, Dropcho S, et al. A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma. Am Soc Clin Oncol 2006;24:7079 (abstract).
4. Kawahara M, Furuse K, Segawa Y, et al. Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer. Br J Cancer 2001;85:939-943.
5. Miyamoto S, Boku N, Ohtsu A, et al. Clinical implications of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimi-dine (S-1). Study Group of S-1 for Gastric Cancer. Int J Oncol 2000;17:653- 658.